Safety and Efficacy of Dinoprostone (Propess) in the Women With Premature Rupture of Membrane or Gestational Age <38
NCT ID: NCT01916291
Last Updated: 2020-03-24
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE2
189 participants
INTERVENTIONAL
2013-08-25
2019-04-04
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Is There an Interest in Repeating the Vaginal Administration of Dinoprostone (PropessĀ®), to Promote Induction of Labor of Pregnant Women at Term?
NCT02888041
Concurrent Membrane Sweeping With Dinoprostone Versus Dinoprostone in Labor Induction of Nulliparas at Term With an Unfavorable Cervix
NCT01792375
Cook Balloon Versus Propess After 12 Hours of Rupture of Membranes
NCT03310333
Propess Versus Prostin for Induction of Labour in Women With Term PROM
NCT04743297
Concurrent Oxytocin With Membrane Sweeping Versus Dinoprostone Pessary in Labor Induction of Nulliparas at Term
NCT02416583
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Propess insertion
Propess insertion group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Propess insertion group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Bishop score \<= 6
Exclusion Criteria
* Active labor
* Vaginal bleeding, unknown origin
* Hypersensitive to Prostaglandin E
* History of asthma, glaucoma
* Infection (birth canal)
* Placental abruption
* Multiparity(\>5)
* Pelvic inflammatory disease
* Heart, lung, kidney disease
* Multiple pregnancy
* Major anomaly
* Fetal distress before induction of labor
20 Years
50 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Seoul National University Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Joong Shin Park, MD PhD
Role: PRINCIPAL_INVESTIGATOR
Seoul National University Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Seoul National University Hospital
Seoul, , South Korea
Seoul Metropolitan Goverment Seoul National University Boramae Medical Center
Seoul, , South Korea
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Propess in PROM or GA<38
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.